Keep us living campaign!

We’re getting mobilised to ensure myeloma patients get the medicines used as standard of care overseas. Please help us! Click here to see how you can help.

7th September media release calling for action can be found below.

Latest News

FRAIL-M Study for Newly-Diagnosed Multiple Myeloma

The Australasian Myeloma Research Consortium (AMaRC) in collaboration with theAustralasian Leukaemia & Lymphoma Group (ALLG) and the Myeloma and Related...
Continue Reading

Consensus statement on the treatment of transplant eligible patients with newly diagnosed multiple myeloma in New Zealand

The New Zealand Myeloma Interest Group is comprised of representative haematologists from District Health Boards around the country with a...
Continue Reading

Multiple Myeloma Summit 2022

Myeloma experts convened in person and online for the 2022 Multiple Myeloma Queenstown Summit, hosted by Myeloma New Zealand. This...
Continue Reading

Multiple Myeloma NZ campaigns for Pharmac to fund medicine

Myeloma New Zealand has started a campaign to press Pharmac into funding a treatment that has been standard-of-care throughout the...
Continue Reading

BLOOD CANCER PATIENTS IMPLORE PHARMAC TO FUND DESPERATELY NEEDED MEDICINE

MEDIA RELEASE 7 September 2022 New Zealanders living with multiple myeloma, a deadly, relapsing/remitting blood cancer, are mounting a major,...
Continue Reading

Burden of Multiple Myeloma

Treatment resources

Clinical trials

Download the ClinTrial Refer App

Q & A – Your Questions Answered

Each month we’ll select questions to answer about multiple myeloma. 

Submit your question by clicking this link 

You may also send an email to: admin@multiplemyeloma.org.nz 

Questions selected and answered will be available on our Q&A page here. 

An email address is needed for administration purposes only and will remain confidential. Questions will be answered in the context of multiple myeloma in New Zealand.

Subscribe to our Newsletter

Join our database to receive newsletters, updates, and seminar invitations.